08 Jul 2019 08:06:00
Report on the results of the sale of warrants offered to existing common shareholders (F53-5)
The results of the sale of Warrants/TSR (F53-5) Report date of securities allocation : 08-Jul-2019 Type of offered securities Warrant Offered to Existing common shareholders Number of offered warrants (units) : 182,222,222 Warrant trading symbol : DOD-W1 Name of warrant : Warrants to Purchase Ordinary Shares of DOD Biotech Public Company Limited No. 1 Offering price (baht per unit) : 0.10 Allocation date : 08-Jul-2019 Number of allotted/subscribed warrants : 182,219,263 (units) Number of remaining warrants (unit) : 2,959 The company will deal with the remaining : The company will cancel the remaining warrants, showing the remaining rights. warrants as follows ________________________________________________________________________________ ___________________ Remark : The Warrant Holders shall be entitled to exercise their rights to purchase ordinary shares on the last business day of May and November throughout the term of the Warrants each year. The First Exercise Date is Friday November 29, 2019 and the Last Exercise Date is the date that the Warrants are valid for 2 years from the Issuance Date, which is on July 7, 2020. ("Last Exercise") Authorized to sign on behalf of the : Mr. Wutichai Anantakul company Position : Director Miss Suwarin Konthong Director ______________________________________________________________________ This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.